Bison Wealth’s Biogen BIIB Stock Holding History

Bison Wealth’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-828	Closed	-$240K	–	226
2018 Q2	$240K	Buy	828 +75	+10%	+$21.1K	0.18%	163
2018 Q1	$206K	Buy	+753	New	+$234K	0.16%	179
2017 Q1	–	Sell	-976	Closed	-$277K	–	175
2016 Q4	$277K	Sell	976 -85	-8%	-$25.2K	0.24%	119
2016 Q3	$332K	Buy	1,061 +214	+25%	+$63.4K	0.28%	97
2016 Q2	$205K	Buy	+847	New	+$223K	0.12%	179
2016 Q1	–	Sell	-793	Closed	-$243K	–	199
2015 Q4	$243K	Buy	+793	New	+$228K	0.14%	182
2015 Q3	–	Sell	-775	Closed	-$313K	–	224
2015 Q2	$313K	Sell	775 -766	-50%	-$307K	0.18%	151
2015 Q1	$651K	Buy	1,541 +270	+21%	+$106K	0.4%	85
2014 Q4	$431K	Buy	+1,271	New	+$411K	0.33%	100

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Bison Wealth's BIIB Position: Q3 2018 in Review

Bison Wealth sold out of Biogen (BIIB) in Q3 2018, closing a stake of 828 shares — an estimated $240K sold.

Bison Wealth first reported a position in BIIB in Q4 2014 and held it in 9 quarters. The position peaked at $651K in Q1 2015. 1,146 funds tracked by Wall St. Rank hold BIIB as of Q3 2018.

Bison Wealth reported no remaining Biogen position as of Q3 2018 after selling out during the quarter.
Bison Wealth sold 828 Biogen shares in Q3 2018, an estimated $240K.
Bison Wealth first reported a position in Biogen in Q4 2014 and held it in 9 quarters.
Bison Wealth's Biogen position peaked at $651K in Q1 2015.
1,146 funds tracked by Wall St. Rank held Biogen as of Q3 2018.

Based on Bison Wealth's 13F filing for Q3 2018, filed 9 Nov 2018.